US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipeline

ET Intelligence Group: Initial trends in pharma results for the June quarter show pressure on the US business, with a double-digit fall in net profit and contraction in operating profitability. The domestic business continued to be a bright